Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Mulder

Showing results (141-150 of 369) with videos related to

Pageof 37
Sort By:
Cancer|February 1, 1984
Small cell lung cancer and the influence of chemotherapy on CFUcs in bone marrowP E Postmus, N H Mulder, E G de Vries, et al.
Acta Haematologica|January 1, 1983
In vitro effects of lithium on granulocyte colony formation in normal men, in hematological disorders and in small-cell carcinoma of the lungE G de Vries, M J van Luyn, N H Mulder, et al.
Anticancer Research|February 19, 2002
Delirium after interleukin-2 and alpha-interferon therapy for renal cell carcinomaJ H van Steijn, P Nieboer, G A Hospers, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|March 1, 1986
Eumelanin-related indolic compounds in the urine of treated melanoma patientsS Pavel, H Elzinga, F A Muskiet, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1985
Phase one study of twice-weekly vindesineN H Mulder, P E Postmus, D T Sleijfer, et al.
Leukemia & Lymphoma|February 1, 1996
Potential use of recombinant human interleukin-6 in clinical oncologyG J Veldhuis, P H Willemse, N H Mulder, et al.
Anticancer Research|September 1, 1993
Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibitionH A Sinnige, H Timmer-Bosscha, G F Peters, et al.
Cancer Research|March 1, 1993
Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cellsS de Jong, A J Kooistra, E G de Vries, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancerJ Buter, R A Janssen, A Martens, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1992
Combination therapy with cisplatin: modulation of activity and tumour sensitivityH J Guchelaar, D R Uges, E G de Vries, et al.
Pageof 37

Showing results (141-150 of 369) with videos related to

Sort By:
Pageof 37
Cancer|February 1, 1984
Small cell lung cancer and the influence of chemotherapy on CFUcs in bone marrowP E Postmus, N H Mulder, E G de Vries, et al.
Acta Haematologica|January 1, 1983
In vitro effects of lithium on granulocyte colony formation in normal men, in hematological disorders and in small-cell carcinoma of the lungE G de Vries, M J van Luyn, N H Mulder, et al.
Anticancer Research|February 19, 2002
Delirium after interleukin-2 and alpha-interferon therapy for renal cell carcinomaJ H van Steijn, P Nieboer, G A Hospers, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|March 1, 1986
Eumelanin-related indolic compounds in the urine of treated melanoma patientsS Pavel, H Elzinga, F A Muskiet, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1985
Phase one study of twice-weekly vindesineN H Mulder, P E Postmus, D T Sleijfer, et al.
Leukemia & Lymphoma|February 1, 1996
Potential use of recombinant human interleukin-6 in clinical oncologyG J Veldhuis, P H Willemse, N H Mulder, et al.
Anticancer Research|September 1, 1993
Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibitionH A Sinnige, H Timmer-Bosscha, G F Peters, et al.
Cancer Research|March 1, 1993
Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cellsS de Jong, A J Kooistra, E G de Vries, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancerJ Buter, R A Janssen, A Martens, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1992
Combination therapy with cisplatin: modulation of activity and tumour sensitivityH J Guchelaar, D R Uges, E G de Vries, et al.
Pageof 37